Epidemiology of isoniazid resistance mutations and their effect on tuberculosis treatment outcomes.

Huyen MN, Cobelens FG, Buu TN, Lan NT, Dung NH, Kremer K, Tiemersma EW, van Soolingen D.

Antimicrob Agents Chemother 2013;57(8):3620-7.

Abstract http://www.ncbi.nlm.nih.gov/pubmed/23689727